ABSTRACT
Paperless operations have been heavily promoted in recent years within the pharmaceutical industry. However, only a few companies have been successful in the transition toward paperless operations. The reasons for this are manifold. There are significant factors: little of the promising technology is mature enough to facilitate a low-risk, large-scale, corporate roll-out, and the regulatory requirements of the pharmaceutical industry have raised questions on “how much needs to be done” to ensure the compliance of a paperless pharmaceutical operation. There are few published, real-life case studies that report clear financial benefits from implementing corporate/enterprise computer systems.
